Simplifying Custom Media From Development To GMP With An End-To-End Approach

This presentation explores Lonza's state-of-the-art custom cell culture media manufacturing capabilities in the USA and Europe, highlighting how these facilities support the rapidly advancing fields of biotechnology and pharmaceuticals. As global leaders in cell culture solutions, Lonza offers a comprehensive suite of services that cater to both standard and highly specialized media formulations. The talk will delve into the cutting-edge technologies and rigorous quality control processes employed at Lonza's facilities, ensuring the production of media that meet the specific needs of clients across research, clinical, and commercial scales. Attendees will gain insights into the collaborative approach Lonza takes in development and manufacturing, emphasizing customization to enhance cell culture performance and reproducibility.

Additionally, the presentation will highlight the RaMP (Rapid Media Prototyping) pilot program and Media Development Lab at Lonza Biologics Tuas, Singapore. RaMP enables the rapid formulation and testing of customer proprietary media as a scale-down model to support successful GMP transition. Complementing this, cell culture media screening services through our Media Development lab assess a wide range of media formulations and culture conditions in parallel to identify those that best promote cell growth, viability, and productivity. Leveraging advanced technologies, these services accelerate optimization through rapid iteration and data-driven refinement. Together, they help researchers and biomanufacturers optimize media development, shorten time to market, and improve the performance and consistency of cell-based applications, including drug discovery, biopharmaceutical manufacturing, and regenerative medicine.